A PHASE III RANDOMIZED, DOUBLE-BLIND, CONTROLLED STUDY OF THE USE OF ANTI-HIV IMMUNE SERUM GLOBULIN (HIVIG) FOR THE PREVENTION OF MATERNAL-FETAL HIV TRANSMISSION IN PREGNANT WOMEN AND NEWBORNS RECEIVING ZIDOVUDINE (AZT):